Master protocols in immuno-oncology: do novel drugs deserve novel designs?

The rapid rise to fame of immuno-oncology (IO) drugs has generated unprecedented interest in the industry, patients and doctors, and has had a major impact in the treatment of most cancers. An interesting aspect in the clinical development of many IO agents is the increasing reliance on nonconventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzarella, Luca, Morganti, Stefania, Marra, Antonio, Trapani, Dario, Tini, Giulia, Pelicci, Piergiuseppe, Curigliano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174064/
https://www.ncbi.nlm.nih.gov/pubmed/32238471
http://dx.doi.org/10.1136/jitc-2019-000475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174064/
https://www.ncbi.nlm.nih.gov/pubmed/32238471
http://dx.doi.org/10.1136/jitc-2019-000475

Ejemplares similares